Product Name:5-Chloroisobenzofuran-1(3H)-one
IUPAC Name:5-chloro-1,3-dihydro-2-benzofuran-1-one
| Packing Unit | Available Stock | Price($) | Quantity |
|---|---|---|---|
| CM161636-1g | in stock | źƞǕ |
|
| CM161636-5g | in stock | ȀźŔ |
|
|
|||
| Product Overview |
5-Chloroisobenzofuran-1(3H)-one (5-Cl-IBF) is a halogenated organic compound with a unique structure that has been studied extensively for its potential applications in a variety of scientific fields. |
| Synthesis Method |
5-Chloroisobenzofuran-1(3H)-one can be synthesized in a variety of ways, including via the reaction of isobenzofurans with chlorine in the presence of a base, such as potassium carbonate. This reaction produces 5-Chloroisobenzofuran-1(3H)-one and a byproduct, which is the corresponding isobenzofuran with a chlorine atom attached. Other methods of synthesis include the reaction of isobenzofurans with chlorine in the presence of a Lewis acid, such as zinc chloride, and the reaction of isobenzofurans with chlorine gas in the presence of a base, such as sodium hydroxide. |
| Chemical Properties |
It is low cost and its ability to be synthesized in a variety of ways. It is potential toxicity. |
| Synthesis and Application |
It has been studied for its antioxidant properties, its ability to react with other compounds, and its ability to act as an inhibitor of certain enzymes. 5-Chloroisobenzofuran-1(3H)-one has been used in the synthesis of several chemicals, including pharmaceuticals, dyes, and other compounds. Additionally, it has been studied as a potential treatment for various diseases, such as cancer, Alzheimer’s, and Parkinson’s. |
| Future Directions |
These include further research into its mechanism of action, its biochemical and physiological effects, and its potential applications in various scientific fields. Additionally, further research into its synthesis methods and its potential toxicity could provide valuable insights into its potential uses. Finally, further research into its potential uses in the treatment of various diseases, such as cancer, Alzheimer’s, and Parkinson’s, could lead to new treatments or therapies. |
Search 
+86 21 5895 0110 
